Insights from Digital Pharma Leaders
Refine Search
Pharmaceutical
Supply chain imperatives are evolving from drug production and delivery that are limited in scope towards a versatile supply chain addressing the needs of multiple stakeholders (such as caregivers, patients and insurance companies). The traditional supply chain approach based on materials requirement planning has progressed to its limits. 17 September 2018
Pharmaceutical
Privately-held Ferring Pharmaceuticals has announced a genomics collaboration with a health-focused tech firm. 30 August 2018
Pharmaceutical
Making patients the owners of and beneficiaries from their own data will be key to making blockchain technology deliver for healthcare as a whole, according to the theory behind a network that could convert siloed information into a connected driver of better research and outcomes. 22 August 2018
Pharmaceutical
“The Russian pharma market is like a huge ocean. If you know who lives in the ocean and what sort of currents the ocean has, then it is all simple and understandable.” 10 August 2018
Pharmaceutical
Sanofi Ventures, the investment arm of French pharma major Sanofi has entered into a $17 million deal with New York-based Click Therapeutics. 23 July 2018
Pharmaceutical
For several years, pharma analysts have predicted varying degrees of impact from nascent blockchain technologies. While some suggest wholesale revolution is in the offing, others anticipate more incremental evolution for a conservative industry that is traditionally resistant to change. 23 July 2018
Pharmaceutical
The first applications of blockchain in healthcare will emerge in the supply chain, says GlobalData. 4 July 2018
Pharmaceutical
In the latest Expert View piece on artificial intelligence (AI), Christopher Bouton, founder and CEO of Vyasa, a provider of software for the life sciences and healthcare industries, analyzes what the future holds for biopharma in an AI-driven world. 9 May 2018
Biotechnology
Akili Interactive, a prescription digital medicine company developing novel treatments for cognitive dysfunction that was founded by London-listed biopharma company PureTech Health, is now $55 million better off following a financing round. 9 May 2018
Pharmaceutical
Ian Churcher, vice president of drug discovery at BenevolentAI, argues that pharma needs to embrace artificial intelligence (AI) to solve the issues which underlie the stagnation of drug discovery, in an Expert View piece. 27 April 2018
Pharmaceutical
The rising cost of drug development, growing need for medicines with an aging population and the greater prevalence of chronic conditions, political uncertainty – many factors suggest that the problem of pricing drugs affordably is not about to away any time soon. 24 April 2018
Pharmaceutical
Mindful that integrating model-informed drug development (MIDD) into more drug applications and advancing its use are US Food and Drug Administration’s (FDA) goals under the Prescription Drug User Fee Amendments of 2017, the agency has stepped up its publicizing of the potential benefits to drugmakers. 20 April 2018
Pharmaceutical
Business, technical, and financial incentives are driving the rapid adoption of cloud-based, commercially available solutions in pharmaceutical research and operations, writes Frank Lin, consultant at Halloran Consulting Group, in an Expert View piece. 27 March 2018
Pharmaceutical
Deals with tech companies are almost seen as essential in pharma today as they consider how to combat challenges such as rising development costs, but rarely is the need for these collaborations spelt out so clearly as it was when two Japanese firms announced a collaboration on Monday. 26 March 2018
Pharmaceutical
Harnessing digital technologies could unlock £22 billion ($30.1 billion) for UK pharma companies over the next decade, according to Accenture. 13 March 2018
Pharmaceutical
In the second of two Expert View columns to whet the appetite for the eyeforpharma Barcelona event in March, Sanofi’s Chief Data Officer (CDO), Milind Kamkolkar, expounds the possibilities of digital and the role of the CDO in this burgeoning landscape. 31 January 2018
Pharmaceutical
In a highly informative and useful Expert View piece, Heather Longden, senior marketing manager for informatics regulatory compliance at the analytical laboratory instrument and software company Waters Corporation, provides insights into the vital role data integrity plays when it comes to analytical testing for drug development. 26 January 2018
Pharmaceutical
Andrew Rut, chief executive of MyMeds&Me, a provider of adverse event and product quality capture software, considers in an Expert View piece how pharma’s ability to run efficient clinical trials is in danger of being compromised by GDPR and a hardening of attitudes on data privacy globally. 9 January 2018
Pharmaceutical
German pharma major Boehringer Ingelheim has increased the size of its corporate venture fund to 250 million euros ($301 million). 3 January 2018
Pharmaceutical
In an area like oncology, innovation is needed not just with the end product, but in the way that researchers get there, finds Rik Van Mol, vice president of R&D strategy at software provider Veeva Systems, in an Expert View piece looking at a leading cancer charity’s modernization of clinical operations. 15 November 2017
Biotechnology
Nona Biosciences has introduced Hu-mAtrIx, an AI-assisted drug discovery platform designed to accelerate the identification and development of antibody-based therapies. 7 March 2025
Pharmaceutical
The new US President has repealed an executive order from October 2023, signed by the Biden administration, that sought to establish rigorous safeguards for artificial intelligence (AI) development. 22 February 2025
Pharmaceutical
US biopharma Incyte and privately-held AI-focused biotech Genesis Therapeutics have entered into a strategic collaboration focused on the research, discovery and development of novel small molecule medicines. 21 February 2025
Pharmaceutical
An Expert View from Kevin Wild, head of pre-sales at software company Syniti. 23 January 2025
Pharmaceutical
French pharmaceutical company Servier and Google Cloud have announced an expanded five-year partnership aimed at leveraging artificial intelligence (AI) and generative AI to accelerate drug research and development. 16 January 2025
Pharmaceutical
A collection of some of the largest US health systems, in collaboration with the Regeneron Genetics Center, have announced the launch of the Truveta Genome Project. 16 January 2025
Pharmaceutical
Privately-held Italian drugmaker Menarini and its oncology-focused subsidiary Stemline Therapeutics have entered into a licensing deal with AI-driven biotech Insilico Medicines. 15 January 2025
Biotechnology
Dyno Therapeutics, a privately-held US genetic technologies company applying AI to enable in vivo gene delivery, has announced that Roche has exercised its option to license a novel capsid for use in a gene therapy program for an undisclosed neurological disease indication. 13 January 2025
Pharmaceutical
Real-world evidence (RWE) specialist Atropos Health has announced a collaboration with US pharma giant Merck & Co. 13 January 2025
Biotechnology
Belgian biopharmaceutical company UCB has entered into a license agreement with Ailux Biologics, the biologics discovery division of XtalPi, to leverage its AI platform. 9 January 2025
Pharmaceutical
Insilico Medicine, a biotechnology firm specializing in artificial intelligence-powered drug discovery, has raised over $100 million in a series E funding round. 8 January 2025
Pharmaceutical
A team of Chinese researchers has identified a promising candidate for glaucoma treatment using artificial intelligence tools. 6 January 2025
Pharmaceutical
The market for artificial intelligence (AI) in cancer care is projected to grow from $2.2 billion in 2024 to $6.3 billion by 2029, reflecting a growth rate of 23.1%, according to a recent study by BCC Research. 31 December 2024
Biotechnology
AI-driven biotech BenevolentAI has announced sweeping changes aimed at refocusing its operations and extending its financial runway into 2027. 20 December 2024
Pharmaceutical
Shanghai-based Fangzhou, has entered into a strategic partnership with the Chinese business of Bristol Myers Squibb China, with the goal of enhancing digital platforms for chronic disease management. 19 December 2024
Pharmaceutical
Swedish biotech company Inify Laboratories has raised approximately 135 million kroner ($12.3 million) through a private placement, supporting a planned expansion into the UK. 16 December 2024
Pharmaceutical
The pharmacovigilance (PV) teams within the pharmaceutical industry currently report allocating 40 to 85% of budgets towards case processing. With case processing volumes growing at a rate of 10 to 15% annually, life sciences organizations are aiming to reduce costs and automate time-consuming processes while maintaining or improving quality. 9 December 2024
Biotechnology
Boston-based AI Proteins, a biotech that uses computational de novo protein design to create therapeutic miniproteins, has entered a research collaboration and option agreement with US pharma major Bristol Myers Squibb. 4 December 2024
Pharmaceutical
A Feature on M&A, licensing, and partnership tapping into AI’s potential to improve drug development. 2 December 2024
Biotechnology
AI-powered protein engineering company Cradle has raised $73 million in a Series B funding. The European firm, which has now raised more than $100 million in total, calls itself the leading platform for AI-powered protein engineering. 27 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze